Cerence INC

Cerence Inc. announces the resignation of Board member Marcy Klevorn, effective July 1, 2026, due to personal reasons.

Cerence AI announced robust second quarter fiscal year 2026 results, surpassing revenue and Adjusted EBITDA expectations and raising its full-year financial outlook.

Cerence Inc. announced robust first quarter fiscal year 2026 results, exceeding Adjusted EBITDA guidance and achieving record free cash flow, driven by a significant patent license payment and accelerating customer momentum for its xUI platform.

Cerence Inc. announced the repurchase of $30 million of its 1.50% Convertible Senior Notes due 2028 at 92% of their principal amount.

Cerence Inc. reported strong fourth quarter and fiscal year 2025 results, exceeding guidance and projecting significant revenue growth for fiscal year 2026, driven by core technology and IP monetization.

Cerence Inc. announced the resolution of its patent infringement disputes with Samsung, resulting in a cross-license agreement and a $49.5 million payment to Cerence.

Cerence Inc. reported a revenue decrease for the second quarter of fiscal year 2026, but saw significant improvements in operating margin and cash flow from operations.

Cerence Inc. reported a decrease in total revenues for the three and nine months ended June 30, 2025, while significantly reducing net losses compared to the prior year due to the absence of large goodwill impairment charges.

Cerence Inc. reports a 15% increase in revenue and a substantial improvement in operating margin for the second quarter of fiscal year 2025, driven by license revenue growth.

Cerence Inc. experienced a significant drop in revenue for the first quarter of fiscal year 2025, primarily due to the early termination of a legacy contract and the termination of services to a separate customer.

Cerence Inc. reported a significant net loss for the third quarter of 2024, primarily due to a large goodwill impairment charge, despite an increase in overall revenue.

Cerence Inc. reported a net loss of $278 million for the quarter ending March 31, 2024, primarily due to a significant goodwill impairment charge.

Cerence Inc. reported a significantly reduced net loss of $18.7 million in fiscal year 2025, alongside a 24% revenue decrease, as it focuses on AI solutions and cost optimization.

Cerence Inc.'s annual 10-K filing reveals a 12.6% revenue increase for fiscal year 2024, alongside a significant net loss due to a goodwill impairment charge.

Cerence Inc. Director Kristi Ann Matus acquired 12,968 shares of common stock, increasing her beneficial ownership to 54,737 shares.

Cerence Inc. Director Marianne Budnik reported the acquisition of 12,968 shares of common stock through a restricted stock unit grant.

Cerence Inc. Director Douglas Lee Davis is scheduled to acquire 12,968 shares of common stock on February 12, 2026, as part of a pre-arranged trading plan.

Cerence Inc. Director Marcy S. Klevorn acquired 12,968 shares of common stock in the form of Restricted Stock Units, vesting on the earlier of one year or the next AGM.

Cerence Inc. Director Marion Harris reported the acquisition of 12,968 shares of common stock through a restricted stock unit grant.

Cerence Inc. CEO Brian M. Krzanich was granted 263,338 Restricted Stock Units, aligning executive incentives with long-term company performance.

Cerence Inc. filed an amendment to its definitive proxy statement to correct a clerical error in the equity compensation plan information.

Cerence Inc. has filed its definitive proxy statement with the SEC, signaling an upcoming shareholder meeting.

Cerence Inc. details fiscal year 2025 achievements in generative AI and diversification, alongside leadership changes and strong executive compensation payouts, in its definitive proxy statement.

Cerence Inc. will hold its annual stockholders meeting on February 13, 2025, seeking votes on director elections, executive compensation, auditor ratification, and an amendment to limit officer liability.

Cerence Inc.'s 2025 proxy statement highlights strategic progress in generative AI, leadership changes, and key governance proposals for shareholder vote.

American Capital Management, Inc. has filed an amended Schedule 13G reporting a 5.6% beneficial ownership stake in Cerence, Inc.

Paradigm Capital Management Inc. has reported beneficial ownership of 5.6% of Cerence Inc. common stock as of March 31, 2026.

Paradigm Capital Management Inc./NY has filed an amended Schedule 13G, reporting a 4.7% beneficial ownership stake in Cerence Inc. common stock.

American Capital Management, Inc. has filed an amended Schedule 13G, revealing a beneficial ownership of 6.9% of Cerence, Inc.'s common stock as of March 31, 2025.

American Capital Management, Inc. has filed a Schedule 13G, revealing a beneficial ownership of 8.1% of Cerence Inc.'s common stock as of December 31, 2024.

Paradigm Capital Management Inc./NY has reported a 6.0% beneficial ownership stake in Cerence Inc. common stock as of December 31, 2024.